Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 89

1.

A new function of Vitamin E-TPGS in the intestinal lymphatic transport of lipophilic drugs: enhancing the secretion of chylomicrons.

Fan Z, Wu J, Fang X, Sha X.

Int J Pharm. 2013 Mar 10;445(1-2):141-7. doi: 10.1016/j.ijpharm.2013.01.070. Epub 2013 Feb 8.

PMID:
23396256
2.
3.

Uptake of lipophilic drugs by plasma derived isolated chylomicrons: linear correlation with intestinal lymphatic bioavailability.

Gershkovich P, Hoffman A.

Eur J Pharm Sci. 2005 Dec;26(5):394-404. Epub 2005 Sep 2.

PMID:
16140514
5.

Influence of vitamin E TPGS poly(ethylene glycol) chain length on apical efflux transporters in Caco-2 cell monolayers.

Collnot EM, Baldes C, Wempe MF, Hyatt J, Navarro L, Edgar KJ, Schaefer UF, Lehr CM.

J Control Release. 2006 Mar 10;111(1-2):35-40. Epub 2006 Jan 10.

PMID:
16410030
6.

Lymphatic transport of orally administered probucol-loaded mPEG-DSPE micelles.

Han L, Yang Q, Shen T, Qing J, Wang J.

Drug Deliv. 2016 Jul;23(6):1955-61. doi: 10.3109/10717544.2015.1028600. Epub 2015 Mar 27.

PMID:
25816053
7.

Influence of vitamin E tocopherol polyethylene glycol succinate 1000 on intestinal absorption of icariside II.

Zhang Z, Lv H, Jia X, Lingling C, Xin J, Yan C, Tan X, Sun E.

Pharmazie. 2012 Jan;67(1):59-62.

PMID:
22393832
8.
9.

Enhanced lymphatic transport of bioactive lipids: cell culture study of polymethoxyflavone incorporation into chylomicrons.

Yao M, Chen J, Zheng J, Song M, McClements DJ, Xiao H.

Food Funct. 2013 Nov;4(11):1662-7. doi: 10.1039/c3fo60335k.

PMID:
24084938
10.

Inhibiting efflux with novel non-ionic surfactants: Rational design based on vitamin E TPGS.

Wempe MF, Wright C, Little JL, Lightner JW, Large SE, Caflisch GB, Buchanan CM, Rice PJ, Wacher VJ, Ruble KM, Edgar KJ.

Int J Pharm. 2009 Mar 31;370(1-2):93-102. doi: 10.1016/j.ijpharm.2008.11.021. Epub 2008 Nov 30.

PMID:
19100824
11.

Monosodium glutamate inhibits the lymphatic transport of lipids in the rat.

Kohan AB, Yang Q, Xu M, Lee D, Tso P.

Am J Physiol Gastrointest Liver Physiol. 2016 Oct 1;311(4):G648-G654. doi: 10.1152/ajpgi.00342.2014. Epub 2016 Aug 11.

PMID:
27514481
12.

Intestinal lymphatic transport of halofantrine in rats assessed using a chylomicron flow blocking approach: the influence of polysorbate 60 and 80.

Lind ML, Jacobsen J, Holm R, Müllertz A.

Eur J Pharm Sci. 2008 Oct 2;35(3):211-8. doi: 10.1016/j.ejps.2008.07.003. Epub 2008 Jul 15.

PMID:
18675904
13.

Vitamin E-TPGS increases absorption flux of an HIV protease inhibitor by enhancing its solubility and permeability.

Yu L, Bridgers A, Polli J, Vickers A, Long S, Roy A, Winnike R, Coffin M.

Pharm Res. 1999 Dec;16(12):1812-7.

PMID:
10644067
14.

Transport of vitamin E by differentiated Caco-2 cells.

Anwar K, Kayden HJ, Hussain MM.

J Lipid Res. 2006 Jun;47(6):1261-73. Epub 2006 Mar 28.

16.

Directed self-assembled nanoparticles of probucol improve oral delivery: fabrication, performance and correlation.

Zhang Z, Jiang S, Liu Z, Niu B, Gu W, Li Y, Cui J.

Pharm Res. 2014 Sep;31(9):2266-75. doi: 10.1007/s11095-014-1321-7. Epub 2014 Mar 4.

PMID:
24590879
17.

Mechanism of inhibition of P-glycoprotein mediated efflux by vitamin E TPGS: influence on ATPase activity and membrane fluidity.

Collnot EM, Baldes C, Wempe MF, Kappl R, Hüttermann J, Hyatt JA, Edgar KJ, Schaefer UF, Lehr CM.

Mol Pharm. 2007 May-Jun;4(3):465-74. Epub 2007 Mar 17.

PMID:
17367162
18.

Solid dispersion of berberine-phospholipid complex/TPGS 1000/SiO₂: preparation, characterization and in vivo studies.

Zhang Z, Chen Y, Deng J, Jia X, Zhou J, Lv H.

Int J Pharm. 2014 Apr 25;465(1-2):306-16. doi: 10.1016/j.ijpharm.2014.01.023. Epub 2014 Jan 20.

PMID:
24456672
19.

Exploring the impact of drug properties on the extent of intestinal lymphatic transport - in vitro and in vivo studies.

Lawless E, Griffin BT, O'Mahony A, O'Driscoll CM.

Pharm Res. 2015 May;32(5):1817-29. doi: 10.1007/s11095-014-1578-x. Epub 2014 Nov 27.

PMID:
25428258

Supplemental Content

Support Center